| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2021 | ULTIMA GENOMICS, INC. | 7979 GATEWAY BLVD STE 101 | NEWARK | CA | 94560-1157 | ALAMEDA | USA | R44HG011060 | Novel sequencing by synthesis chemistry to further reduce the cost of nucleic acid sequencing | 000 | 2 | NIH | 5/3/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $617,578 ) |
| | 2021 | 2021 | ULTIMA GENOMICS, INC. | 7979 GATEWAY BLVD STE 101 | NEWARK | CA | 94560-1157 | ALAMEDA | USA | R44HG011060 | Novel sequencing by synthesis chemistry to further reduce the cost of nucleic acid sequencing | 001 | 2 | NIH | 4/1/2021 | $617,578 |
| | 2021 | 2020 | ULTIMA GENOMICS, INC. | 7979 GATEWAY BLVD STE 101 | NEWARK | CA | 94560-1157 | ALAMEDA | USA | R44HG011060 | Novel sequencing by synthesis chemistry to further reduce the cost of nucleic acid sequencing | 000 | 1 | NIH | 1/15/2021 | $0 |
| | 2021 | 2019 | ULTIMA GENOMICS, INC. | 7979 GATEWAY BLVD STE 101 | NEWARK | CA | 94560-1157 | ALAMEDA | USA | R44HG010558 | Novel sequencing by synthesis platform to greatly reduce the cost of nucleic acid sequencing | 000 | 2 | NIH | 11/12/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,382,286 ) |
| | 2020 | 2020 | ULTIMA GENOMICS, INC. | 7979 GATEWAY BLVD STE 101 | NEWARK | CA | 94560-1157 | ALAMEDA | USA | R44HG011060 | Novel sequencing by synthesis chemistry to further reduce the cost of nucleic acid sequencing | 000 | 1 | NIH | 4/27/2020 | $1,382,286 |
| | 2020 | 2019 | ULTIMA GENOMICS, INC. | 7979 GATEWAY BLVD STE 101 | NEWARK | CA | 94560-1157 | ALAMEDA | USA | R44HG010558 | Novel sequencing by synthesis platform to greatly reduce the cost of nucleic acid sequencing | 000 | 1 | NIH | 9/14/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $2,224,579 ) |
| | 2019 | 2019 | ULTIMA GENOMICS, INC. | 7979 GATEWAY BLVD STE 101 | NEWARK | CA | 94560-1157 | ALAMEDA | USA | R44HG010558 | Novel sequencing by synthesis platform to greatly reduce the cost of nucleic acid sequencing | 002 | 2 | NIH | 9/18/2019 | $1,925,138 |
| | 2019 | 2019 | ULTIMA GENOMICS, INC. | 7979 GATEWAY BLVD STE 101 | NEWARK | CA | 94560-1157 | ALAMEDA | USA | R44HG010558 | Novel sequencing by synthesis platform to greatly reduce the cost of nucleic acid sequencing | 000 | 1 | NIH | 5/22/2019 | $299,441 |
| | 2019 | 2019 | ULTIMA GENOMICS, INC. | 7979 GATEWAY BLVD STE 101 | NEWARK | CA | 94560-1157 | ALAMEDA | USA | R44HG010558 | Novel sequencing by synthesis platform to greatly reduce the cost of nucleic acid sequencing | 001 | 1 | NIH | 9/17/2019 | $0 |
|
|
